Sanara MedTech - 34 Year Stock Price History | SMTI
Historical daily share price chart and data for Sanara MedTech since 1991 adjusted for splits and dividends. The latest closing stock price for Sanara MedTech as of June 11, 2025 is 28.94.
- The all-time high Sanara MedTech stock closing price was 15000.00 on February 15, 1991.
- The Sanara MedTech 52-week high stock price is 39.08, which is 35% above the current share price.
- The Sanara MedTech 52-week low stock price is 25.86, which is 10.6% below the current share price.
- The average Sanara MedTech stock price for the last 52 weeks is 32.31.
| Sanara MedTech Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 32.3418 | 33.1000 | 38.1200 | 27.0200 | 28.9400 | -12.83% |
| 2024 | 33.4311 | 40.9400 | 40.9400 | 26.8600 | 33.2000 | -19.22% |
| 2023 | 38.4512 | 40.5000 | 49.6800 | 26.3300 | 41.1000 | -9.67% |
| 2022 | 27.8204 | 30.7900 | 45.5000 | 18.3100 | 45.5000 | 53.98% |
| 2021 | 32.7934 | 45.6700 | 45.6700 | 22.8600 | 29.5500 | -40.78% |
| 2020 | 22.0933 | 15.9500 | 52.7500 | 8.0000 | 49.9000 | 209.94% |
| 2019 | 7.0891 | 3.5900 | 16.1000 | 2.7500 | 16.1000 | 393.11% |
| 2018 | 6.3190 | 6.0000 | 10.9900 | 2.0000 | 3.2650 | -45.58% |
| 2017 | 7.1267 | 3.8000 | 10.0000 | 3.8000 | 6.0000 | 58.31% |
| 2016 | 5.8701 | 6.7000 | 8.9000 | 3.6000 | 3.7900 | -57.18% |
| 2015 | 7.8218 | 5.7700 | 10.5000 | 4.7300 | 8.8500 | 60.91% |
| 2014 | 9.8839 | 10.4000 | 13.8900 | 5.5000 | 5.5000 | -47.62% |
| 2013 | 6.7339 | 4.0000 | 10.5000 | 4.0000 | 10.5000 | 162.50% |
| 2012 | 17.0408 | 39.0000 | 40.0000 | 3.1300 | 4.0000 | -89.87% |
| 2011 | 47.2119 | 41.0000 | 79.5000 | 20.5000 | 39.5000 | -1.25% |
| 2010 | 75.8405 | 210.0000 | 210.0000 | 33.0000 | 40.0000 | -81.82% |
| 2009 | 269.8913 | 435.0000 | 435.0000 | 180.0000 | 220.0000 | -34.33% |
| 2008 | 283.1736 | 101.0000 | 500.0000 | 101.0000 | 335.0000 | 231.68% |
| 2007 | 50.0818 | 15.0000 | 110.0000 | 5.0000 | 101.0000 | 1920.00% |
| 2006 | 14.8485 | 45.0000 | 45.0000 | 5.0000 | 5.0000 | -66.67% |
| 2005 | 61.0741 | 101.0000 | 105.0000 | 15.0000 | 15.0000 | -88.00% |
| 2004 | 115.0889 | 27.0000 | 160.0000 | 27.0000 | 125.0000 | 362.96% |
| 2003 | 78.3600 | 51.0000 | 115.0000 | 26.0000 | 27.0000 | -50.91% |
| 2002 | 248.3333 | 400.0000 | 600.0000 | 50.0000 | 55.0000 | -87.78% |
| 2001 | 1160.3455 | 2000.0000 | 2200.0000 | 380.0000 | 450.0000 | -70.00% |
| 2000 | 1572.2945 | 200.0000 | 3600.0000 | 200.0000 | 1500.0000 | 650.00% |
| 1999 | 834.8892 | 600.0000 | 2000.0000 | 200.0000 | 200.0000 | -71.43% |
| 1998 | 2090.6065 | 3300.0000 | 3900.0000 | 700.0000 | 700.0000 | -78.79% |
| 1997 | 3350.8531 | 1100.0000 | 7600.0000 | 1100.0000 | 3300.0000 | 135.71% |
| 1996 | 2239.3125 | 500.0000 | 4500.0000 | 400.0000 | 1400.0000 | 180.00% |
| 1995 | 291.6667 | 300.0000 | 1000.0000 | 100.0000 | 500.0000 | 0.00% |
| 1992 | 1344.0737 | 1718.7500 | 3750.0000 | 312.5000 | 2500.0000 | 45.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.265B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.273B | 21.83 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |